Low efficacy of an ultra-short term, once-daily dose triple therapy with omeprazole, azithromycin, and secnidazole for Helicobacter pylori eradication in peptic ulcer
Rev. Hosp. Clin. Fac. Med. Univ. Säo Paulo
;
57(1): 9-14, Jan.-Feb. 2002. tab
Article
in English
| LILACS
| ID: lil-311299
RESUMO
PURPOSE:
To determine the eradication rate of an ultra-short treatment schedule for Helicobacter pylori infection in a population with peptic ulcers, using omeprazole, secnidazole, and azithromycin in a once-daily dose for 3 days.METHODS:
Thirty patients with peptic ulcer diagnosed by upper endoscopy and for Helicobacter pylori infection by rapid urease test and histologic examination received omeprazole 40 mg, secnidazole 1000 mg, and azithromycin 500 mg, administered once daily for 3 days. A follow-up exam was performed 12 weeks after the end of the treatment. Patients who were negative for Helicobacter pylori infection by rapid urease test and histologic examination were considered cured.RESULTS:
Patients were predominantly female, and the mean age was 50 years. Duodenal peptic ulcer was found in 73 percent of the patients. Eradication was achieved in 9 of the 28 (32 percent) patients as determined from the follow-up endoscopic exam. The eradication rate by intention to treat was 30 percent. Side effects were present in 3 percent of the patients, and compliance to treatment was total.CONCLUSIONS:
In spite of the low rate of side effects and good compliance, the eradication index was low. A possible drawback of this therapy is that it reduces the efficacy of macrolide and nitroimidazole compounds in subsequent treatments
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Peptic Ulcer
/
Omeprazole
/
Helicobacter pylori
/
Azithromycin
/
Metronidazole
/
Anti-Ulcer Agents
/
Anti-Bacterial Agents
/
Antiprotozoal Agents
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
English
Journal:
Rev. Hosp. Clin. Fac. Med. Univ. Säo Paulo
Journal subject:
Medicine
Year:
2002
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
University of Säo Paulo/BR
Similar
MEDLINE
...
LILACS
LIS